Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-24-009126

CEO and CFO bought 30,500 shares at $12.49 ($380,945)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Snehal CEO and CFO 2024-03-05 Purchase +30,500 $12.49 $380,945 5,343,777 D
Open-market purchases · 30,500 sh · avg $12.49 · $380,945
Loading xslF345X05/ownership.xml…